A new Japanese trial showed no benefit of low-dose, once-daily aspirin in the primary prevention of cardiovascular events in patients with multiple risk factors. The Japanese Primary Prevention Project included 14,464 patients from 60 to 85 years of age. More
The five drafts concern policies related to FDA oversight of drugs produced by state-licensed pharmacies, federal facilities, and outsourcing facilities. They are available for public comment for 90 days. More
Calvin H. Knowlton, BS Pharm, MDiv, PhD, has been named this year’s Remington Honor Medal award winner. Known for his "out-of-the-box" thinking, Knowlton was nominated by a colleague for the development of a practice model for hospice patients. More
